To view this email as a web page, click here.
 
HIGHLIGHTS   |  October 18, 2019
 
Untangling Breast Cancer Disparities in San Francisco
A new study looked at the characteristics of diagnosed breast cancer cases in San Francisco.
Read more
 
 
TAS-102 Prolongs Survival in Metastatic Gastric, GEJ Adenocarcinoma
TAS-102 improved overall survival, compared with placebo, in patients with metastatic gastric or gastroesophageal junction (GEJ) cancer.
Read more
 
 
IN CASE YOU MISSED IT
 
Bioinformatics Analysis Identifies Key Biomarkers
Genetic profiles of thyroid cancer shed light on molecular mechanisms.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.